OPKO Health, Inc. (FRA:XCY)

Market Cap	897.59M
Revenue (ttm)	547.23M
Net Income (ttm)	-153.75M
Shares Out	n/a
EPS (ttm)	-0.21
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Average Volume	1,434
Open	1.153
Previous Close	1.117
Day's Range	1.110 - 1.153
52-Week Range	1.033 - 1.656
Beta	n/a
RSI	42.55
Earnings Date	Feb 27, 2026

About OPKO Health

OPKO Health, Inc., a healthcare company, engages in the diagnostics and pharmaceuticals businesses in the United States, Ireland, Chile, Spain, Israel, Mexico, and internationally. The company’s Diagnostics segment operates BioReference Laboratories that offer laboratory testing services for the detection, diagnosis, evaluation, monitoring, and treatment of diseases, including esoteric testing, molecular diagnostics, anatomical pathology, genetics, women’s health, and correctional healthcare to physician offices, clinics, hospitals, employers, ...

• Industry: Medical Laboratories
• Founded: 2007
• Employees: 2,997
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: XCY

Financial Performance

In 2024, OPKO Health's revenue was $713.14 million, a decrease of -17.41% compared to the previous year's $863.50 million. Losses were -$53.22 million, -71.82% less than in 2023.

Financial numbers in USD